Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study
Glutathione (GSH) is a major endogenous antioxidant. Several studies have shown GSH redox imbalance and altered GSH levels in Alzheimer’s disease (AD) patients. Early detection is crucial for the outcome of AD. However, whether GSH can serve as a biomarker during the very early-phase of AD, such as...
Guardado en:
Autores principales: | Chieh-Hsin Lin, Hsien-Yuan Lane |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fec705f00af9448caca8004e0ceed222 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mild cognitive impairment and its management in older people
por: Eshkoor SA, et al.
Publicado: (2015) -
From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution
por: Cheng YW, et al.
Publicado: (2017) -
Feasibility and first results of a group program to increase the frequency of cognitively stimulating leisure activities in people with mild cognitive impairment (AKTIVA–MCI)
por: Tesky VA, et al.
Publicado: (2017) -
The Potential Role of miRNAs in Cognitive Frailty
por: Giulia Carini, et al.
Publicado: (2021) -
Evaluation of Available Cognitive Tools Used to Measure Mild Cognitive Decline: A Scoping Review
por: Chian Thong Chun, et al.
Publicado: (2021)